【摘要】 原发性肝癌为我国常见的恶性肿瘤之一。吴万垠教授致力于中医肿瘤临床三十余年，在治疗原发性肝癌方面学验俱丰。吴万垠教授认为，本病病机为本虚标实，肝郁脾虚，瘀毒互结是贯穿原发性肝癌发病和发展的重要原因。他在前人的基础上结合现代药理学自拟新健脾理气方，在临床上根据肝癌的发展规律在不同阶段辨证指导用药，可起到延长生存期、改善患者生活质量、增效减毒的作用。更多还原

【Abstract】 Primary liver cancer is one of the most common malignant tumor in China. Professor WU Wan-yin has been committed to the clinical practice of treatment of tumors with traditional Chinese medicine for more than 30years, and is experienced in primary liver cancer. He believes that the pathogenesis of primary liver cancer is characterized by deficiency in origin and excess in superficiality. Besides, hepatic stagnation causing splenic deficiency and the combination of blood stasis and toxin contribute to the significant reason for the occurrence and development of primary liver cancer. Based on the practice of former practitioners and the achievement in modern pharmacology, Professor WU Wan-yin established the New Jianpi Liqi Decoction. The application of the New Jianpi Liqi Decoction in various stages of primary liver cancer following the principles of treatment based on syndrome differentiation can achieve the effects of prolonging survival time,improving life quality,enhancing the efficacy and reducing the toxicity.更多还原